12th Dec 2007 17:35
Vectura Group plc12 December 2007 Vectura Group plc ADDITIONAL LISTING APPLICATION Chippenham, UK, 12 December 2007: Vectura Group plc (LSE: VEC) ("Vectura" or the"Company"), the drug development company, today announces that application hasbeen made to the UK Listing Authority and to the London Stock Exchange(together, "Admission"), for a listing of 3,628,145 ordinary shares of 0.025pence each. The applications made are in respect of shares agreed to be issued to BoehringerIngelheim International GmbH by virtue of an agreement entered into by deedbetween Boehringer Ingelheim International and the Company announced to themarket on the 26 November 2007. It is expected that admission will occur at 8.00am on 17 December 2007. Subject to Admission becoming effective, and in conformity with the FinancialService Authority's Disclosure and Transparency Rules, Vectura would like tonotify the market of the following: The Company's issued share capital will consist of 319,435,509 ordinary shareswith a nominal value of 0.025 pence per share, with voting rights (one vote perordinary share). The company does not hold any shares in treasury. The above figure of 319,435,509 ordinary shares may be used by shareholders asthe denominator for the calculations by which they will determine if they arerequired to notify their interest in, or a change to their interest in, theCompany under the Financial Service Authority's Disclosure and TransparencyRules. Enquiries: Vectura Group plc Tel: 01249 667 612Anne Hyland, Chief Financial Officer This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
VEC.L